SIMILAR PATTERNS OF AMINO ACIDS FOR 5V9I_C_SAMC1505
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mvh | CRYPTIC LOCIREGULATOR 4 (Schizosaccharomycespombe) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 339TRP A 340TYR A 381ASN A 409HIS A 410 | None | 0.49A | 5v9iC-1mvhA:24.2 | 5v9iC-1mvhA:36.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.22A | 5v9iC-1pegA:25.8 | 5v9iC-1pegA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 160TRP A 161TYR A 204ASN A 241HIS A 242TYR A 283CYH A 306 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) | 0.46A | 5v9iC-1pegA:25.8 | 5v9iC-1pegA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g46 | PBCV-1 HISTONEH3-LYS 27METHYLTRANSFERASE (ParameciumbursariaChlorella virus1) |
PF00856(SET) | 5 | GLY A 15TYR A 50ASN A 69HIS A 70TYR A 105 | NoneSAH A 301 (-3.1A)SAH A 301 (-3.0A)SAH A 301 (-4.8A)MLZ C 215 (-3.7A) | 1.07A | 5v9iC-2g46A:7.7 | 5v9iC-2g46A:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h21 | RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE (Pisum sativum) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 81SER A 221ASN A 242HIS A 243TYR A 287 | SAM A 801 (-3.7A)SAM A 801 (-4.3A)SAM A 801 (-2.9A)SAM A 801 (-4.9A)SAM A 801 (-4.8A) | 0.50A | 5v9iC-2h21A:6.3 | 5v9iC-2h21A:21.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TRP A 152HIS A 220TYR A 261CYH A 289 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.46A | 5v9iC-2r3aA:28.1 | 5v9iC-2r3aA:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 151TRP A 152TYR A 193ASN A 219HIS A 220TYR A 261CYH A 287 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 0.46A | 5v9iC-2r3aA:28.1 | 5v9iC-2r3aA:34.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | ASN A3906HIS A3907TYR A3944PHE A3946CYH A3957 | SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A)None ZN A4970 ( 2.3A) | 0.85A | 5v9iC-2w5zA:11.9 | 5v9iC-2w5zA:25.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) | 0.22A | 5v9iC-2w5zA:11.9 | 5v9iC-2w5zA:25.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840TYR A3883ASN A3906HIS A3907CYH A3957 | SAH A4971 ( 3.7A)NoneSAH A4971 (-3.1A)SAH A4971 (-4.7A) ZN A4970 ( 2.3A) | 0.72A | 5v9iC-2w5zA:11.9 | 5v9iC-2w5zA:25.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 136TRP A 137HIS A 210TYR A 248CYH A 275 | SAH A 305 (-3.8A)NoneNoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.50A | 5v9iC-3bo5A:26.0 | 5v9iC-3bo5A:33.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A 136TRP A 137TYR A 178ASN A 209HIS A 210TYR A 248PHE A 286CYH A 273 | SAH A 305 (-3.8A)NoneSAH A 305 (-4.0A)SAH A 305 (-3.4A)NoneSAH A 305 (-4.9A)SAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 0.70A | 5v9iC-3bo5A:26.0 | 5v9iC-3bo5A:33.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.30A | 5v9iC-3n71A:5.5 | 5v9iC-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 102TRP A 103HIS A 170TYR A 207CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.46A | 5v9iC-3ooiA:18.8 | 5v9iC-3ooiA:29.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 7 | GLY A 102TRP A 103TYR A 146ASN A 169HIS A 170TYR A 207CYH A 219 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) | 0.49A | 5v9iC-3ooiA:18.8 | 5v9iC-3ooiA:29.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 7 | GLY A2151TRP A2152TYR A2194ASN A2217HIS A2218TYR A2255CYH A2268 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNone ZN A 1 ( 2.5A) | 0.55A | 5v9iC-3opeA:17.4 | 5v9iC-3opeA:28.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 6 | GLY A2151TRP A2152TYR A2194HIS A2218TYR A2255CYH A2270 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.4A)NoneNone ZN A 1 (-2.7A) | 1.48A | 5v9iC-3opeA:17.4 | 5v9iC-3opeA:28.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rc0 | N-LYSINEMETHYLTRANSFERASESETD6 (Homo sapiens) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 74TYR A 223ASN A 251HIS A 252TYR A 285 | SAM A 484 (-3.4A)SAM A 484 (-3.6A)SAM A 484 (-3.1A)NoneSAM A 484 (-4.8A) | 0.70A | 5v9iC-3rc0A:6.6 | 5v9iC-3rc0A:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4au7 | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2 (Mus musculus) |
PF00856(SET) | 5 | ASN A 182HIS A 183TYR A 217PHE A 221CYH A 229 | SAH A1247 (-3.1A)SAH A1247 (-4.6A)NoneNone ZN A1248 ( 2.3A) | 0.59A | 5v9iC-4au7A:8.5 | 5v9iC-4au7A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 6 | GLY A1561TRP A1562TYR A1605ASN A1628HIS A1629CYH A1678 | 0UM A1804 (-3.5A)None0UM A1804 (-4.2A)0UM A1804 (-3.3A)None ZN A1803 ( 2.2A) | 0.64A | 5v9iC-4fmuA:17.6 | 5v9iC-4fmuA:28.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1563TRP A1562TYR A1605TYR A1579PHE A1664 | NoneNone0UM A1804 (-4.2A)0UM A1804 (-4.5A)0UM A1804 (-4.8A) | 1.26A | 5v9iC-4fmuA:17.6 | 5v9iC-4fmuA:28.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.64A | 5v9iC-4mi5A:11.1 | 5v9iC-4mi5A:30.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 7 | GLY A 457TRP A 458TYR A 493ASN A 551HIS A 552TYR A 593CYH A 612 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-4.0A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) | 0.65A | 5v9iC-4qeoA:29.3 | 5v9iC-4qeoA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.54A | 5v9iC-4w2rA:15.7 | 5v9iC-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 6 | GLY A5408TYR A5451ASN A5474HIS A5475TYR A5512CYH A5525 | SAH A5602 (-3.6A)SAH A5602 (-4.5A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 0.56A | 5v9iC-4z4pA:13.4 | 5v9iC-4z4pA:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | GLY A5410TYR A5451HIS A5475TYR A5512CYH A5525 | NoneSAH A5602 (-4.5A)NoneNone ZN A5601 ( 2.2A) | 1.43A | 5v9iC-4z4pA:13.4 | 5v9iC-4z4pA:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 6 | GLY A4782TYR A4825ASN A4848HIS A4849TYR A4886CYH A4899 | SAH A5002 (-3.5A)SAH A5002 (-4.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) | 0.76A | 5v9iC-5f59A:13.2 | 5v9iC-5f59A:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 5 | GLY A4784TYR A4825HIS A4849TYR A4886CYH A4899 | NoneSAH A5002 (-4.5A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) | 1.42A | 5v9iC-5f59A:13.2 | 5v9iC-5f59A:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | ASN A3906HIS A3907TYR A3944PHE A3946CYH A3957 | SAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A)None ZN A4002 ( 2.3A) | 0.91A | 5v9iC-5f6lA:12.9 | 5v9iC-5f6lA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 6 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4001 (-3.4A)NoneSAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 0.53A | 5v9iC-5f6lA:12.9 | 5v9iC-5f6lA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | GLY A3842TYR A3883HIS A3907TYR A3944CYH A3957 | NoneNoneSAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 1.33A | 5v9iC-5f6lA:12.9 | 5v9iC-5f6lA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fbh | EXTRACELLULARCALCIUM-SENSINGRECEPTOR (Homo sapiens) |
no annotation | 5 | MET B 473GLY B 474SER B 426ASN B 472TYR B 421 | None | 1.39A | 5v9iC-5fbhB:undetectable | 5v9iC-5fbhB:18.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.33A | 5v9iC-5kjmA:6.0 | 5v9iC-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.76A | 5v9iC-5ls6A:14.3 | 5v9iC-5ls6A:18.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1074TRP A1075TYR A1118ASN A1141HIS A1142TYR A1179CYH A1191 | SAM A1304 ( 3.2A)NoneSAM A1304 (-3.8A)SAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) | 0.50A | 5v9iC-5lsuA:19.7 | 5v9iC-5lsuA:28.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1076TYR A1118HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 4.6A)SAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.03A | 5v9iC-5lsuA:19.7 | 5v9iC-5lsuA:28.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5teg | N-LYSINEMETHYLTRANSFERASEKMT5A (Homo sapiens) |
PF00856(SET) | 5 | GLY A 227TYR A 271ASN A 298HIS A 299TYR A 336 | SAM A 401 ( 4.0A)SAM A 401 (-4.1A)SAM A 401 (-3.2A)NoneSAM A 401 (-4.8A) | 0.26A | 5v9iC-5tegA:12.5 | 5v9iC-5tegA:23.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | MET A1048GLY A1049TRP A1050ASN A1112HIS A1113CYH A1170 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A) ZN A1504 (-2.2A) | 1.37A | 5v9iC-5tuyA:41.0 | 5v9iC-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 11 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.35A | 5v9iC-5tuyA:41.0 | 5v9iC-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 11 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.22A | 5v9iC-5vsdA:41.1 | 5v9iC-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | MET A1136GLY A1137TRP A1138TYR A1173HIS A1201TYR A1242CYH A1258 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.48A | 5v9iC-5vsdA:41.1 | 5v9iC-5vsdA:76.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.70A | 5v9iC-5wg6A:14.2 | 5v9iC-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15ASN A 205HIS A 206TYR A 239CYH A 261 | SAM A 502 ( 3.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) ZN A 503 (-2.2A) | 0.49A | 5v9iC-5xxgA:5.8 | 5v9iC-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 7 | GLY A1156TRP A1157TYR A1200ASN A1223HIS A1224TYR A1261CYH A1273 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.9A)SAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 0.61A | 5v9iC-6cenA:19.4 | 5v9iC-6cenA:undetectable |